Perelel, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Perelel, Inc. - overview
Established
2020
Location
Los Angeles, CA, US
Primary Industry
Food
About
Based in California, US, and founded in 2020 by its Co-CEO Alexandra Taylor, and Victoria Thain Gioia, and co-founder Dr. Banafsheh Bayati, Perelel Inc. operates as a manufacturer of prenatal health vitamins for stage womanhood. In November 2025, Perelel raised USD 27 million in growth funding from new investor Prelude Growth Partners, with participation from returning investors Unilever Ventures, Willow Growth Partners, and Selva Ventures.
Perelel Inc. offerings include a conception support pack, 1st-trimester prenatal pack, 2nd-trimester prenatal pack, 3rd-trimester prenatal pack, PCOS support pack, libido support, daily iron ease, mom multi support pack (for postpartum and early motherhood), women’s daily vitamin trio (for women of all reproductive age), and men’s multi support pack, as well as supplemental products.
Current Investors
Unilever Ventures, Willow Growth Partners, Selva Ventures
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Internet
Website
www.perelelhealth.com
Verticals
E-commerce, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.